In the news · 48h FDA 37 Eli Lilly 19 Roche 10 Merck & Co. (MSD) 9 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Novo Nordisk 3

Company

Merck & Co. (MSD)

Maker of Keytruda; MSD outside North America.

Approvals 1 Trials 8 Deals 1

Now

Deals & business · 2h ago

Wnt drug gives MSD first eye disease win after EyeBio deal

1 outlet Merck & Co. (MSD)

Approvals & regulatory · 14h ago

Merck Welireg, Eisai Lenvima combo approved for kidney cancer

1 outlet Merck & Co. (MSD)

Trials & R&D · 18h ago

DME red flag in Merck Brunello phase III? Surrozen finishes rich

1 outlet Merck & Co. (MSD)

Deals & business · 19h ago

Merck reveals study success, and possible safety worries, for eye drug hopeful

1 outlet Merck & Co. (MSD)

Trials & R&D · 19h ago

MSD’s DME drug could challenge anti-VEGF reign, late-stage study suggests

1 outlet Merck & Co. (MSD)

Approvals & regulatory · 21h ago

Merck’s experimental eye drug matches Roche’s VEGF inhibitor but safety concerns emerge

1 outlet Merck & Co. (MSD) Roche

Trials & R&D · 22h ago

Merck’s return to ophthalmology snags first success

1 outlet Merck & Co. (MSD)

Trials & R&D · 23h ago

Merck’s diabetic macular edema therapy succeeds in Phase 2b/3 trial

1 outlet Merck & Co. (MSD)

Trials & R&D · yesterday

Merck sees pivotal victory for $3B eye disease prospect

1 outlet Merck & Co. (MSD)